THERAMETRICS Trademark

Trademark Overview


On Friday, November 22, 2013, a trademark application was filed for THERAMETRICS with the United States Patent and Trademark Office. The USPTO has given the THERAMETRICS trademark a serial number of 79142915. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Tuesday, November 21, 2023. This trademark is owned by THERAMetrics holding AG. The THERAMETRICS trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical products and preparations for the treatment of cardiovascular and respiratory diseases, pulmonary fibrosis, sarcoidosis, lung disease, viral diseases, and infectious diseases; chemical preparations for sanitary purposes for medicine; pharmaceutical products for the treatment of idiopathic pulmonary arterial hypertension, familial pulmonary arterial hypertension, scleroderma, lupus erythematosus associated pulmonary hypertension, congenital systemic-to-pulmonary shunts associated pulmonary hypertension, portal hypertension associated pulmonary hypertension, HIV infection associated pulmonary hypertension, drugs and toxins associated pulmonary hypertension, glycogen storage disease associated pulmonary hypertension, Gaucher disease associated pulmonary hypertension, hereditary hemorrhagic telangiectasia associated pulmonary hypertension, hemoglobinopathies associated pulmonary hypertension, myeloproliferative disorders associated pulmonary hypertension, pulmonary veno-occl...

Scientific research to order; conducting of research and development in the medical, pharmaceutical, pharmacological, biochemical and/or medical technology fields for others; conducting to order clinical studies and tests, namely, conducting clinical trials for others; assessment to order of scientific projects, namely, conducting scientific feasibility studies; scientific research consulting in the nature of evaluation to order of clinical studies and experiments; providing technical advice relating to operation of computers; providing scientific cooperations in the nature of providing scientific information in the field of pharmaceutical research; conducting scientific research projects in the medical, pharmaceutical, pharmacological, biochemical, and/or medical technology fields for others; scientific analysis laboratories
therametrics

General Information


Serial Number79142915
Word MarkTHERAMETRICS
Filing DateFriday, November 22, 2013
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateTuesday, November 21, 2023
Registration Number4654772
Registration DateTuesday, December 16, 2014
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, September 30, 2014

Trademark Statements


Description of MarkThe mark consists of the stylized term "THERAMetrics" with three parallel diagonal lines appearing in front of the letter "M" in "THERAMetrics".
Goods and ServicesPharmaceutical products and preparations for the treatment of cardiovascular and respiratory diseases, pulmonary fibrosis, sarcoidosis, lung disease, viral diseases, and infectious diseases; chemical preparations for sanitary purposes for medicine; pharmaceutical products for the treatment of idiopathic pulmonary arterial hypertension, familial pulmonary arterial hypertension, scleroderma, lupus erythematosus associated pulmonary hypertension, congenital systemic-to-pulmonary shunts associated pulmonary hypertension, portal hypertension associated pulmonary hypertension, HIV infection associated pulmonary hypertension, drugs and toxins associated pulmonary hypertension, glycogen storage disease associated pulmonary hypertension, Gaucher disease associated pulmonary hypertension, hereditary hemorrhagic telangiectasia associated pulmonary hypertension, hemoglobinopathies associated pulmonary hypertension, myeloproliferative disorders associated pulmonary hypertension, pulmonary veno-occlusive disease associated pulmonary hypertension, pulmonary capillary hemangiomatosis associated pulmonary hypertension, persistent pulmonary hypertension of the newborn, left-sided atrial or ventricular heart disease associated pulmonary hypertension, left-sided valvular heart disease associated pulmonary hypertension, pulmonary hypertension associated with chronic obstructive pulmonary disease, pulmonary hypertension associated with interstitial lung diseases, pulmonary hypertension associated with sleep disordered-breathing, pulmonary hypertension associated with alveolar hypoventilation disorders, pulmonary hypertension associated with chronic exposure to high altitude, pulmonary hypertension associated with developmental abnormalities, pulmonary hypertension due to chronic thrombotic and embolic diseases, pulmonary embolism due to tumor, parasites, foreign material, pulmonary hypertension associated with in situ thrombosis, pulmonary hypertension associated with sarcoidosis, pulmonary hypertension associated with histiocytosis X, pulmonary hypertension associated with lymphangiomatosis, pulmonary hypertension associated with sickle-cell disease, Eisenmenger syndrome, chronic fatigue syndrome, bronchial asthma, rheumatoid arthritis, lupus, Goodpasture's syndrome, Wegener's granulomatosis, type 1 diabetes mellitus, Hashimoto's thyroiditis, Grave's disease, multiple sclerosis, Guillain-Barre syndrome, Addison's disease, acute disseminated encephalomyelitis, antiphospholipid antibody syndrome, aplastic anemia, myasthenia gravis, opsoclonus myoclonus syndrome, optic neuritis, Ord's thyroiditis, acute respiratory distress syndrome, acute lung injury, Hamman-Rich syndrome, idiopathic pulmonary fibrosis, bronchiolitis obliterans, hypersensitivity pneumonitis, lymphangiomyomatosis (LAM), usual interstitial pneumonia (UIP), Von Gierke syndrome, Osler-Weber-Rendu-Syndrome, small cell lung carcinoma, cystic fibrosis, tuberculosis, Hepatitis B virus infections, psoriasis, allergic dermatitis, scar keloids, pyogenic granulomas, blistering disease, Kaposi sarcoma in AIDS patients, systemic sclerosis, persistent hyperplastic vitreous syndrome, diabetic retinopathy, retinopathy of prematurity, choroidal neovascularization, inflammatory bowel disease, periodontal disease, ascites, peritoneal adhesions, endometriosis, uterine bleeding, ovarian cysts, ovarian hyperstimulation, osteomyelitis, osteophyte formation, HIV-induced bone marrow angiogenesis, early diabetic nephropathy, cancer and malignancies and their metastases in numerous organs, hemangiomas, vasculitis, Sjögren's disease, DiGeorge syndrome, hereditary haemorrhagic telangiectasia, cavernous hemangioma, cutaneous hemangioma, lymphatic malformations, transplant arteriopathy, vascular anastomoses, adipose tissue in obesity, chronic allograft rejections; chemical preparations intended for healing, health care or medical and veterinary purposes, namely, chemical preparations for treating inflammatory, cardiovascular and respiratory diseases, pulmonary fibrosis, sarcoidosis, lung disease, viral diseases, and infectious diseases; chemical reagents for medical or veterinary purposes; diagnostic preparations for medical purposes; radiological contrast substances for medical purposes; detergents for medical purposes; medicated mouth care and treatment preparations; medicated skin care preparations
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesScientific research to order; conducting of research and development in the medical, pharmaceutical, pharmacological, biochemical and/or medical technology fields for others; conducting to order clinical studies and tests, namely, conducting clinical trials for others; assessment to order of scientific projects, namely, conducting scientific feasibility studies; scientific research consulting in the nature of evaluation to order of clinical studies and experiments; providing technical advice relating to operation of computers; providing scientific cooperations in the nature of providing scientific information in the field of pharmaceutical research; conducting scientific research projects in the medical, pharmaceutical, pharmacological, biochemical, and/or medical technology fields for others; scientific analysis laboratories

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, July 2, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, July 2, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameTHERAMetrics holding AG
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCH

Party NameTHERAMetrics holding AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCH

Party NameTHERAMetrics holding AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCH

Trademark Events


Event DateEvent Description
Friday, March 14, 2014NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, March 14, 2014REFUSAL PROCESSED BY MPU
Friday, March 14, 2014NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, April 4, 2014REFUSAL PROCESSED BY IB
Friday, February 21, 2014SN ASSIGNED FOR SECT 66A APPL FROM IB
Tuesday, February 25, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, March 1, 2014APPLICATION FILING RECEIPT MAILED
Monday, March 10, 2014ASSIGNED TO EXAMINER
Thursday, March 13, 2014NON-FINAL ACTION WRITTEN
Thursday, July 3, 2014NOTIFICATION OF FINAL REFUSAL EMAILED
Friday, May 23, 2014TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, June 5, 2014ASSIGNED TO LIE
Tuesday, June 10, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, June 10, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, July 3, 2014FINAL REFUSAL WRITTEN
Thursday, July 3, 2014FINAL REFUSAL E-MAILED
Wednesday, September 10, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 30, 2014PUBLISHED FOR OPPOSITION
Tuesday, December 16, 2014REGISTERED-PRINCIPAL REGISTER
Monday, March 16, 2015FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Friday, May 8, 2015FINAL DISPOSITION PROCESSED
Wednesday, August 20, 2014TEAS REQUEST FOR RECONSIDERATION RECEIVED
Wednesday, August 20, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, August 21, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, August 22, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 27, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, September 30, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Friday, May 8, 2015FINAL DISPOSITION NOTICE SENT TO IB
Friday, June 12, 2015FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, December 16, 2019COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Monday, February 10, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, July 2, 2021CANCELLED SECTION 71
Sunday, July 24, 2022TOTAL INVALIDATION PROCESSED BY THE IB
Sunday, June 16, 2024DEATH OF INTERNATIONAL REGISTRATION
Sunday, June 16, 2024NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Tuesday, June 28, 2022TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Wednesday, March 2, 2022TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Tuesday, June 28, 2022INVALIDATION PROCESSED